Provided by Tiger Trade Technology Pte. Ltd.

Candel Therapeutics, Inc.

4.91
-0.1300-2.58%
Volume:1.20M
Turnover:5.87M
Market Cap:359.63M
PE:-6.81
High:5.04
Open:4.96
Low:4.80
Close:5.04
52wk High:8.69
52wk Low:4.25
Shares:73.24M
Float Shares:45.48M
Volume Ratio:0.82
T/O Rate:2.63%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7210
EPS(LYR):-0.7210
ROE:-64.58%
ROA:-25.95%
PB:6.93
PE(LYR):-6.81

Loading ...

Jul 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 11, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 11, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 11, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 11, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 11, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 28, 2024

Major Issues Report

Form 8-K - Current report
May 30, 2024

Major Issues Report

Form 8-K - Current report
May 23, 2024

Major Issues Report

Form 8-K - Current report
May 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 14, 2024

Major Issues Report

Form 8-K - Current report
Apr 25, 2024

Major Issues Report

Form 8-K - Current report
Apr 25, 2024

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Apr 11, 2024

Major Issues Report

Form 8-K - Current report
Apr 09, 2024

Major Issues Report

Form 8-K - Current report
Apr 04, 2024

Major Issues Report

Form 8-K - Current report
Mar 28, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 28, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]